Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 163,078 | 158,134 | 132,469 | 172,227 | 115,694 |
| Marketable Securities | 133,902 | 142,669 | 168,714 | 188,045 | 208,087 |
| Receivables | 82,448 | 66,761 | 59,938 | 70,938 | 69,340 |
| Inventories | 51,678 | 51,710 | 49,833 | 65,545 | 51,520 |
| TOTAL | $442,689 | $429,091 | $422,500 | $512,649 | $457,018 |
| Non-Current Assets | |||||
| PPE Net | 131,112 | 126,650 | 122,473 | 111,584 | 109,081 |
| Intangibles | 279,324 | 285,208 | 296,253 | 285,356 | 282,398 |
| Other Non-Current Assets | 60,045 | 63,999 | 66,211 | 57,151 | 61,929 |
| TOTAL | $470,481 | $475,857 | $484,937 | $454,091 | $453,408 |
| Total Assets | $913,170 | $904,948 | $907,437 | $966,740 | $910,426 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 22,159 | 31,237 | 32,004 | 28,489 | 27,509 |
| Accrued Expenses | 111,156 | 87,267 | 89,081 | 84,705 | 81,936 |
| TOTAL | $138,358 | $125,785 | $129,155 | $122,693 | $122,341 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 0 | 0 | N/A | 1,000 |
| Other Non-Current Liabilities | 44,401 | 45,211 | 45,096 | 44,220 | 44,365 |
| TOTAL | $76,229 | $76,876 | $79,794 | $76,182 | $77,680 |
| Total Liabilities | $214,587 | $202,661 | $208,949 | $198,875 | $200,021 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 411,962 | 396,968 | 361,854 | 333,934 | 327,877 |
| Common Shares | 17 | 16 | 14 | 14 | 13 |
| Retained earnings | -2,775,530 | -2,703,626 | -2,612,373 | -2,500,715 | -2,384,552 |
| Other shareholders' equity | 16,440 | 16,103 | 20,859 | 6,294 | -1,046 |
| TOTAL | $698,583 | $702,287 | $698,488 | $767,865 | $710,405 |
| Total Liabilities And Equity | $913,170 | $904,948 | $907,437 | $966,740 | $910,426 |